Ingevity Corp. Files 8-K on Financials

Ticker: NGVT · Form: 8-K · Filed: 2025-08-04T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, results-of-operations

Related Tickers: NGVT

TL;DR

NGVT filed an 8-K on Aug 4, 2025, covering financial results. Check it for details.

AI Summary

On August 4, 2025, Ingevity Corp. filed an 8-K report detailing results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 4920 O'Hear Avenue, Suite 400, North Charleston, South Carolina.

Why It Matters

This filing provides investors with crucial updates on Ingevity Corp.'s financial performance and operational status, enabling informed investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on Ingevity Corp.'s Results of Operations and Financial Condition, and to provide Financial Statements and Exhibits.

When was this 8-K report filed?

This 8-K report was filed on August 4, 2025.

What is Ingevity Corp.'s principal executive office address?

Ingevity Corp.'s principal executive office is located at 4920 O'Hear Avenue, Suite 400, North Charleston, South Carolina 29405.

What is Ingevity Corp.'s fiscal year end?

Ingevity Corp.'s fiscal year ends on December 31.

What is the SEC file number for Ingevity Corp.?

The SEC file number for Ingevity Corp. is 001-37586.

From the Filing

0001653477-25-000104.txt : 20250804 0001653477-25-000104.hdr.sgml : 20250804 20250804162748 ACCESSION NUMBER: 0001653477-25-000104 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250804 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250804 DATE AS OF CHANGE: 20250804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ingevity Corp CENTRAL INDEX KEY: 0001653477 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 474027764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37586 FILM NUMBER: 251180714 BUSINESS ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 BUSINESS PHONE: 8437402300 MAIL ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 8-K 1 ngvt-20250804.htm 8-K ngvt-20250804 false Ingevity Corp 0001653477 0001653477 2025-08-04 2025-08-04 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________  FORM 8-K _______________________________________________________________________ CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 August 4, 2025 Date of Report (date of earliest event reported) __________________________________________________________________________ INGEVITY CORPORATION (Exact name of registrant as specified in its charter) __________________________________________________________________________  Delaware 001-37586 47-4027764 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 4920 O'Hear Avenue Suite 400 North Charleston South Carolina 29405 (Address of principal executive offices) (Zip code) Registrant’s telephone number, including area code: 843 - 740-2300 Not Applicable (Former name or former address, if changed since last report) _____________________________________________________________________________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock ($0.01 par value) NGVT New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐ Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act o _____________________________________________________________________________________________________ ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION On August 4, 2025 , Ingevity Corporation ("Ingevity") announced its preliminary financial results for the three and six months ended June 30, 2025 which are attached as Exhibit 99.1 to this Current Report on Form 8-K

View on Read The Filing